A ‘TAD’ easier to calculate!

نویسندگان

چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A TAD closer to ATM

Ataxia telangiectasia mutated (ATM) has been known for decades as the main kinase mediating the DNA double-strand break response. Our recent findings suggest that its major role at the sites of breaks likely resides in its ability to modify both the local chromatin landscape and the global chromosome organization in order to promote repair accuracy.

متن کامل

Adam Steensberg Tad

Please cite this article in press as: Steensberg, A. Beyond biomarkers in drug discovery and d 1359-6446/ 2014 Elsevier Ltd. All rights reserved. http://dx.doi.org/10.1016/j.drudis.2014.12.009 market; this is no longer a certainty. Today, most new drugs compete against numerous therapies, including nonpharmaceutical options. To create new value these therapies need to provide benefits beyond ex...

متن کامل

A Neuro-Fuzzy System to Calculate a

Internationality as a concept is being applied ambiguously and erroneously, particularly in the world of academic journal publication where it is often used as a quality indicator. Although different qualitative criteria have been used by scientometrists in order to attempt a measure of internationality in various contexts, it is now clear that the literal definition of internationality is a mi...

متن کامل

TAD disruption as oncogenic driver.

Topologically Associating Domains (TADs) are conserved during evolution and play roles in guiding and constraining long-range regulation of gene expression. Disruption of TAD boundaries results in aberrant gene expression by exposing genes to inappropriate regulatory elements. Recent studies have shown that TAD disruption is often found in cancer cells and contributes to oncogenesis through two...

متن کامل

A TAD better for myeloma therapy?

In this issue of Blood, Lokhorst and colleagues report on the results of HOVON-50, a phase 3 randomized trial designed to evaluate the effects of thalidomide during induction treatment and as maintenance in patients with multiple myeloma. There were 556 patients randomly assigned either to 3 cycles of VAD or to TAD. All patients were to receive high-dose melphalan with autologous stem cell supp...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: The Annals of The Royal College of Surgeons of England

سال: 2014

ISSN: 0035-8843,1478-7083

DOI: 10.1308/rcsann.2014.96.4.320a